CN113004315B - Histidine-triggered organic hydrogel fluorescent probe and preparation method and application thereof - Google Patents
Histidine-triggered organic hydrogel fluorescent probe and preparation method and application thereof Download PDFInfo
- Publication number
- CN113004315B CN113004315B CN202110175668.XA CN202110175668A CN113004315B CN 113004315 B CN113004315 B CN 113004315B CN 202110175668 A CN202110175668 A CN 202110175668A CN 113004315 B CN113004315 B CN 113004315B
- Authority
- CN
- China
- Prior art keywords
- histidine
- mog
- fluorescent
- preparation
- triggered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 239000000017 hydrogel Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 13
- 230000001960 triggered effect Effects 0.000 title claims abstract description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000000499 gel Substances 0.000 claims abstract description 29
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims abstract description 24
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims abstract description 24
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000005493 rutin Nutrition 0.000 claims abstract description 24
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229960004555 rutoside Drugs 0.000 claims abstract description 24
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 13
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 13
- 108010059993 Vancomycin Proteins 0.000 claims abstract description 10
- 239000012046 mixed solvent Substances 0.000 claims abstract description 10
- 229910052751 metal Inorganic materials 0.000 claims abstract description 9
- 239000002184 metal Substances 0.000 claims abstract description 9
- NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 claims abstract description 9
- 229960000564 nitrofurantoin Drugs 0.000 claims abstract description 9
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 claims abstract description 8
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 7
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 7
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 7
- 239000011648 beta-carotene Substances 0.000 claims abstract description 7
- 229960002747 betacarotene Drugs 0.000 claims abstract description 7
- 229960003165 vancomycin Drugs 0.000 claims abstract description 7
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 claims abstract description 7
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 7
- 239000002243 precursor Substances 0.000 claims abstract description 6
- 239000000523 sample Substances 0.000 claims abstract description 6
- 239000011782 vitamin Substances 0.000 claims abstract description 6
- 229940088594 vitamin Drugs 0.000 claims abstract description 6
- 229930003231 vitamin Natural products 0.000 claims abstract description 6
- 235000013343 vitamin Nutrition 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000411 inducer Substances 0.000 claims abstract description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims abstract 3
- QMKYBPDZANOJGF-UHFFFAOYSA-N benzene-1,3,5-tricarboxylic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC(C(O)=O)=C1 QMKYBPDZANOJGF-UHFFFAOYSA-N 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 238000010438 heat treatment Methods 0.000 claims description 11
- 239000003446 ligand Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 239000013110 organic ligand Substances 0.000 claims description 3
- 238000001514 detection method Methods 0.000 abstract description 16
- 229940024606 amino acid Drugs 0.000 abstract description 6
- 150000001413 amino acids Chemical class 0.000 abstract description 6
- 230000008859 change Effects 0.000 abstract description 4
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 22
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 230000000171 quenching effect Effects 0.000 description 11
- 229960002885 histidine Drugs 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 9
- 238000010791 quenching Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 238000002189 fluorescence spectrum Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 235000013373 food additive Nutrition 0.000 description 5
- 239000002778 food additive Substances 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 4
- 238000007664 blowing Methods 0.000 description 4
- 150000001746 carotenes Chemical class 0.000 description 4
- 235000005473 carotenes Nutrition 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 229920000877 Melamine resin Polymers 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000020676 food antibiotic Nutrition 0.000 description 3
- 238000004020 luminiscence type Methods 0.000 description 3
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 229960001572 vancomycin hydrochloride Drugs 0.000 description 3
- LCTORFDMHNKUSG-XTTLPDOESA-N vancomycin monohydrochloride Chemical compound Cl.O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 LCTORFDMHNKUSG-XTTLPDOESA-N 0.000 description 3
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 2
- GNWUOVJNSFPWDD-XMZRARIVSA-M Cefoxitin sodium Chemical compound [Na+].N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)CC1=CC=CS1 GNWUOVJNSFPWDD-XMZRARIVSA-M 0.000 description 2
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 229930182844 L-isoleucine Natural products 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 229930195722 L-methionine Natural products 0.000 description 2
- HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 description 2
- 229910007926 ZrCl Inorganic materials 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 229960003022 amoxicillin Drugs 0.000 description 2
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 229960004099 azithromycin Drugs 0.000 description 2
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 2
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 2
- 229960003644 aztreonam Drugs 0.000 description 2
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229960002129 cefixime Drugs 0.000 description 2
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 2
- 229960003016 cefoxitin sodium Drugs 0.000 description 2
- 229960000484 ceftazidime Drugs 0.000 description 2
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 2
- 229960001668 cefuroxime Drugs 0.000 description 2
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 description 2
- 229960002626 clarithromycin Drugs 0.000 description 2
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940110377 dl- arginine Drugs 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- -1 flavonoid vitamin Chemical class 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 229960000282 metronidazole Drugs 0.000 description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 2
- 238000005424 photoluminescence Methods 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 description 2
- 229960003053 thiamphenicol Drugs 0.000 description 2
- 229960005053 tinidazole Drugs 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N Aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 description 1
- 229930028154 D-arginine Natural products 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000000941 anti-staphylcoccal effect Effects 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 238000009920 food preservation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- 238000012803 optimization experiment Methods 0.000 description 1
- 235000019449 other food additives Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000011540 sensing material Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004729 solvothermal method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/183—Metal complexes of the refractory metals, i.e. Ti, V, Cr, Zr, Nb, Mo, Hf, Ta or W
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention discloses a histidine-triggered organic hydrogel fluorescent probe, a preparation method and application thereof, wherein histidine is used as a fluorescent trigger, and Zr is used as a fluorescent trigger 4+ As precursors and gel inducers, N-dimethylformamide and H are used 2 O is used as a mixed solvent to construct a histidine-triggered metal organic hydrogel fluorescent switch probe Zr-MOG-His. The method is used for stably, selectively and highly sensitively detecting and capturing the vitamins, amino acids and antibiotics remained in water, and the detection results show specificity to Rutin (RUT), beta-Carotene (CAR), vancomycin (VHE) and nitrofurantoin (FAN), good fluorescence change efficiency and excellent detection limit and practicability.
Description
Technical Field
The invention relates to the field of material chemistry and sensing, in particular to a histidine-triggered organic hydrogel fluorescent probe, and a preparation method and application thereof.
Background
Development of a multifunctional fluorescent probe is important for selection and optimization of optical sensor substrate materials. Luminescent metal-organic gels have been attracting attention as an emerging class of metal-organic hybrid materials that combine some of the properties of metal-organic complexes and colloids, and have been increasingly used in the field of optical sensors.
Vitamins are trace elements necessary for maintaining normal physiological functions of human beings, and have important functions and effects on the life health of human beings. Rutin (vitamin P, rut) is a flavonoid vitamin that needs to be ingested by the human body for eliminating excessive free radicals in the human body. It has subtle effects on the development of various body systems and the removal of disease factors. However, although Rut has many benefits to humans, such as allergic people, obese patients and people with weak capillaries are not suitable to ingest such substances too much, and it is also notable that rutin is a serious hazard to aquatic organisms. Beta-carotene is a classical carotenoid which is effective in preventing diseases such as cancers, but is erroneously added to partial foods such as fried foods, which can cause toxic and side effects on human bodies. Antibiotics are broad spectrum drugs used to treat human diseases and bacterial infections. Vancomycin and nitrofurantoin are two common classes of anti-staphylococcus aureus, sensitive bacterial drugs, often used in clinical medicine. However, both antibiotics have been prohibited from being added to food. Illegally added into foods to achieve the effect of food preservation is a common means of illegal merchants. Therefore, it is necessary to effectively detect food additives and antibiotics in these foods.
The optical sensor has the advantages of high recognition efficiency, visual effect and good expression effect. Fluorescence sensors based on fluorescence quenching mode are a very classical type of optical detector and have been favored by many researchers. In addition, fluorescence sensors based on fluorescence enhancement modes have been attracting attention by researchers due to their excellent sensitivity and other characteristics. Both have advantages and disadvantages. Here, we have constructed a multifunctional fluorescence sensor using a metal organic gel as an optical substrate material for detecting and identifying these common food additives and antibiotics.
Disclosure of Invention
Histidine (His) is an essential basic amino acid in human body, contains carboxylic acid and a plurality of N binding sites, and has very important functions of regulating the steady state of the human body, balancing acid and alkali, controlling inflammatory reaction and improving the immunity of the human body. The invention provides a zirconium-based metal organic gel Zr-MOG-His with coordination induction luminescence effect triggered by amino acid, which is used for specifically and sensitively identifying and capturing Rut by taking His as a fluorescence starting 'key' and aiming at the defects of the existing experience and technology such as electrochemical method, colorimetric method, chromatographic method and the like. The electron-rich structure of His forms a good bridging site with trimesic acid that is strongly competitive. His serves as a good Lewis base in the system to regulate the pH, reduce the acidic environment of the system and promote the formation of a gel system. And the acidic environment easily causes His to be protonated, and positively charged N-containing functional groups block Zr 4+ Is of the interaction of (a) to indirectly induce Zr 4+ Form stable interaction force with-COO-.
Preparation method of histidine-triggered organic hydrogel fluorescent probe, which uses histidine as fluorescent trigger, zr 4+ As precursors and gel inducers, N-dimethylformamide and H are used 2 O is used as a mixed solvent to construct a histidine-triggered metal organic hydrogel fluorescent switch probe Zr-MOG-His.
The preparation method comprises the steps of DMF and H 2 O was transferred into the reaction vessel and then shaken well until thoroughly mixed, DMF and H 2 The volume ratio of O is 3:5-9:1; adding the ligand into the reaction container, and mixing and dissolving; the reaction vessel is sufficiently vibrated for 10-30min until the organic ligand in the system is completely dissolved, then 0.05mmoL-1 mole of Zr is added 4+ Adding into a mixed solvent; heating and vibrating the reaction system, and then placing the reaction system into an electrothermal blowing drying box, and heating the reaction system for 30min to 12h at the temperature of 80 to 120 ℃ to form white columnar gel.
The ligand is trimesic acid, terephthalic acid, graphene quantum dots, perovskite quantum dots, melamine and g-C 3 N 4 And organic acid or inorganic-organic hybrid nanodots having a plurality of carboxyl groups or amino groups.
According to the preparation method, the ligand is trimesic acid, and the molar ratio of His to trimesic acid is 1:1
The preparation method comprises DMF and H 2 The volume ratio of O is 7:3.
An organic hydrogel fluorescent probe prepared according to any one of the preparation methods.
The application of the organic hydrogel fluorescent probe is used for stably, selectively and highly sensitively detecting and capturing the vitamins, amino acids and antibiotics remained in water, and the detection results show specificity, good fluorescence change efficiency, excellent detection limit and practicability to Rutin (RUT), beta-Carotene (CAR), vancomycin (VHE) and nitrofurantoin (FAN).
DMF and H 2 O was transferred into the reaction vessel and then shaken well until thoroughly mixed, DMF and H 2 The volume ratio of O is 7:3 (at a mixing ratio of 3:5 to 9:1Any condition is satisfied); trimesic acid (ligands can be replaced by terephthalic acid, graphene quantum dots, perovskite quantum dots, melamine, g-C 3 N 4 Organic acid or inorganic-organic hybrid nanodots with a plurality of carboxyl groups or amino groups, etc.) are added into the reaction vessel, and His and trimesic acid are added according to the mole ratio of 1:1 (the mole ratio can be optionally regulated according to the requirement, the photoluminescence of other amino acids forming gel is verified or excluded through a plurality of experiments, and the experimental results show that after tryptophan, tyrosine, phenylalanine, arginine and histidine form metal organic gel, no obvious photoluminescence exists in the wavelength range of 300-500nm, and experimental record data are shown in table 1). His is used as an alkaline bridging ligand and Zr 4+ Coordination, thereby triggering the action of Zr-MOG-His fluorescence on. Sufficiently shaking the reaction vessel for 10-30min until the organic ligand in the system is completely dissolved, and then adding Zr 4+ (between 0.05mmoL and 1 mole of salt which can be fully dissolved or dispersed in the mixed solvent of DMF and water is added into the mixed solvent; heating and vibrating the reaction system, and then placing the reaction system into an electrothermal blowing drying oven for heating for 30min-12h at 80-120 ℃ in which the heating temperature is inversely proportional to the time, the higher the temperature is, the shorter the synthesis time is, the synthesis temperature is controlled within 25-170 ℃ to form white columnar gel, and the heating time is determined by the conditions of material ratio and the like. His triggered coordination induced luminescence metal organic gel prepared by the preparation method is fluorescent on after gel is formed, and the fluorescent on efficiency is enhanced according to the increase of His concentration; meanwhile, rutin, beta-carotene, vancomycin and nitrofurantoin have good stimulus response to the freeze-dried xerogel so as to generate quenching effect, and L-alanine and D-arginine have certain fluorescence enhancement effect to the freeze-dried xerogel.
Table 1 Metal organic gel formed by partial amino acids and its luminous mechanism
The invention has the following advantages:
1. the target detection object can be specifically identified in water or serum;
2. a fluorescent switch probe with ligand-to-metal ligand coordination induced luminescence effect resulting in probe fluorescence on. And the effects of rapidly identifying and capturing rutin, beta-carotene, vancomycin and nitrofurantoin are achieved through energy resonance transfer or internal filtering effect.
3. Mixing detection with other food additives or antibiotics still does not affect the detection effect of the target detection object, and the quenching effect is instantly completed due to the synergistic effect of internal filtration effect or energy resonance transfer between the host and the object, so that the fluorescent probe has the advantages of rapid detection, sensitivity and good selectivity.
Drawings
FIG. 1 is an optical physical diagram of Zr-MOG-His gel;
FIG. 2 is a UV photopic image of Zr-MOG-His gel;
FIG. 3 optimization experiment of histidine to BTC ratio;
FIG. 4 is a scanning electron microscope and transmission electron microscope photograph of Zr-MOG-His xerogel;
FIG. 5 (a) structural formula of histidine, structural formula (b) trimesic acid;
FIG. 6 structural formulas of a target detection object and a target antibiotic;
FIG. 7 (a) fluorescence emission spectra of Zr-MOG-His xerogel identifying different kinds of food additives, (b) concentration gradient fluorescence emission spectra of Zr-MOG-His xerogel captured for Rut identification, (c) Rut Linear fitting map;
FIG. 8 (a) fluorescence change efficiency of Zr-MOG-His xerogel to recognize different antibiotics, (b) concentration gradient fluorescence emission spectrum of Zr-MOG-His xerogel to FAN recognition capture, (c) FAN linear fitting map;
FIG. 9 Zr-MOG-His xerogel, BTC, his, rut, zr-MOG-His+Rut solid state ultraviolet absorbance spectra;
FIG. 10 Zr-MOG-His xerogel recognizes and captures solid state fluorescence lifetimes before and after Rut;
Detailed Description
The present invention will be described in detail with reference to specific examples.
Example 1:
the preparation method comprises the following concrete implementation steps:
1. hydrothermal solvothermal method: DMF and H 2 O was mixed in any ratio and transferred to a glass vial, and then shaken well until thoroughly mixed. BTC (0.1 g,0.05 mmol) and His were separately added to vials. And carrying out ultrasonic vibration treatment on the small glass bottle for 20s-3min until the ligand in the system is completely dispersed and dissolved. Then ZrCl is added 4 (0.046 g,0.2 mmol) was added to the mixed solvent. And finally, placing the reaction system into an electrothermal blowing drying oven, and heating at 80-120 ℃ for 30min-12h to form white columnar gel. The gel is then eluted with double distilled water or ethanol. In a high-speed centrifuge at 12000r min -1 High speed centrifugation was used to aid in removal of residual DMF from the gel. Finally, the eluted hydrogel is placed in a freeze drying box and dried in vacuum at the temperature of minus 110 ℃ to further remove residual DMF and uncrystallized H in the gel 2 O。
2. Ultrasonic assisted thermal method: the specific reactant amounts are the same as above. And placing the fully mixed and dissolved precursor in an ultrasonic heater, and carrying out ultrasonic heating to obtain the white columnar gel.
3. Microwave assisted method: the specific reactant consumption is the same as above, and the reaction vessel is replaced by a reaction kettle and a polytetrafluoroethylene lining. And (5) fully mixing the dissolved precursors in a microwave oven, and heating by microwaves to obtain the white columnar gel.
His: optimization of BTC ratio
Weighing a certain amount of His and BTC according to different molar ratios, respectively, pouring into a container containing DMF and H 2 The O mixed solvent is fully shaken in a glass bottle until the O mixed solvent is completely dissolved. ZrCl of the same mass 4 Respectively adding into the above small glass bottles. Stirring was carried out well at room temperature until complete dissolution. Finally, the mixed precursor is processedPlacing in an electrothermal blowing drying oven for heating at 120deg.C for 12 hr after fully sealing. Obtaining the Zr-MOG-His with different proportions of His and BTC. The residual DMF was removed by treatment with double distilled water and absolute ethanol and washing 3-10 times, respectively. The experimental results showed that the fluorescence intensity was highest when the ratio was 1:1 (FIG. 3).
Example 2: detection of Rut with Zr-MOG-His as fluorescent probe
The xerogel after freeze-drying of Zr-MOG-His hydrogels was used for Rut detection. Zr-MOG-His xerogel (100 mg) was dispersed in 5mL H 2 O or DMSO, sonicated for 30min until completely dispersed. The formulated dispersion was used to identify capture experiments.
Remove 100. Mu.L of Zr-MOG-His to centrifuge tubes with solutions of various target analytes (2.9 mL) and incubate at room temperature for 30-60min. After complete mixing of Zr-MOG-His and target analyte, the samples were used for subsequent stimulus response experiments of target analyte to Zr-MOG-His. Fluorescence spectra were recorded by excitation at 370 nm.
Rutin and beta-carotene selective identification (rutin is taken as an example)
His: freeze-dried gel of BTC-optimized gel was used for the stimulus response experiment of rutin. Zr-MOG-His xerogel (200 mg) was dispersed in 5mL DMF and sonicated for 20-50min until completely dispersed. The finally obtained dispersion liquid is used for a stimulus response experiment on rutin.
mu.L of Zr-MOG-His was transferred to a centrifuge tube containing solutions of different target analytes and incubated at room temperature for 30min. And finally, the obtained mixed dispersion liquid is used for selectively verifying rutin. The following food additives were selected as target analytes for rutin to conduct the selectivity experiments: rutin (RUT), carotene (CAR), L-aspartic acid (L-Asp), L-valine (L-Val), L-glutamic acid (L-Ula), L-histidine (L-His), DL-arginine (DL-Arg), melamine (Mel), sucrose (Suc), glucose (Glu), D-fructose (D-Fru), lactose (Lac), L-leucine (L-Lea), L-methionine (L-Met), L-isoleucine (L-Iso).
As can be seen from FIG. 7 (a), different food additives have different levels of quenching effect, wherein RUT and CAR significantly quench the fluorescence of Zr-MOG-HisAnd the fluorescent quenching efficiency is high. In addition, it is notable that the relative fluorescence intensity of Zr-MOG-His showed a linear decrease with increasing RUT concentration (FIG. 7 b). According to the Stern-Volmer (SV) formula: f (F) 0 /F=1+K SV [M]Standard calculation formula lod=3σ/K of detection limit SV The value of Ksv and LOD are estimated. Wherein F is 0 And F is the fluorescence intensity of Zr-MOG-His gel dispersion before and after adding a certain concentration of RUT. [ M ]]Is the molar concentration of Zr-MOG-His gel, and K SV Is the quenching constant and σ is the standard deviation of the blank amount. With reference to fig. 7c, the detection limit of the RUT is calculated to be 0.011 μm, so that the RUT has good practical application potential and low sensitivity.
As shown in FIG. 7, rutin has excellent stimulus response results to Zr-MOG-His, and the energy resonance transfer efficiency is as high as 97.4% according to fluorescence lifetime. This may be due to the strong interaction between the host (Zr-MOG-His) and the guest (Rut) leading to fluorescence resonance energy transfer. This point is further demonstrated by the broad integrated overlap between the fluorescence emission spectrum of the Zr-MOG-His xerogel and the UV absorption spectrum of Rut. In addition, the solid state ultraviolet absorption spectrum of the Zr-MOG-His xerogel appears to be a distinct absorption band around 350nm-500nm after recognizing Rut, which suggests that a certain interaction is formed between the Zr-MOG-His xerogel and Rut, which may be attributed to the stable conjugated structure of the Zr-MOG-His xerogel itself, namely BTC, and stable pi-pi interaction is formed between His and Rut, so that the Zr-MOG-His xerogel can selectively capture Rut and generate fluorescent off signals. Based on the fluorescence lifetime before and after recognition, the mechanism of static quenching between hosts and guests is excluded (static quenching does not lead to a change in fluorescence lifetime). Therefore, the Zr-MOG-His xerogel becomes a sensing material with great potential for selectively identifying and capturing rutin.
Example 3: the selective identification of the antibiotics vancomycin and nitrofurantoin (as exemplified by nitrofurantoin), the procedure is as above, and the specific target antibiotics are selected as follows:
procaine Penicillin (PPG), thiamphenicol (TPL), vancomycin Hydrochloride (VHE), azithromycin (ATN), ceftazidime (CAE), cefoxitin sodium (CXN), cefuroxime (CRM), penicillin sodium (PCN), cefixime (CIE), amoxicillin (AMO), aztreonam (AEM), clarithromycin (CTN), tinidazole (TDE), metronidazole (MIE), nitrofurantoin (FAN).
Different antibiotics have different degrees of quenching or fluorescence enhancement effects, wherein FAN significantly quenched the fluorescence of Zr-MOG-His and had higher fluorescence quenching efficiency (fig. 8 a). In addition, it is notable that the relative fluorescence intensity of Zr-MOG-His showed a linear decrease with increasing FAN concentration (FIG. 8 b). According to the Stern-Volmer (SV) formula: f (F) 0 /F=1+K SV [M]Standard calculation formula lod=3σ/K of detection limit SV The value of Ksv and LOD are estimated. Wherein F is 0 And F is the fluorescence intensity of Zr-MOG-His gel dispersion before and after adding certain concentration of FAN. [ M ]]Is the molar concentration of Zr-MOG-His gel, and K SV Is the quenching constant and σ is the standard deviation of the blank amount. Referring to FIG. 7c, the detection limit of the obtained FAN was calculated to be 0.597. Mu.M, so that the obtained Zr-MOG-His has good recognition ability for FAN.
It will be understood that modifications and variations will be apparent to those skilled in the art from the foregoing description, and it is intended that all such modifications and variations be included within the scope of the following claims.
Claims (4)
1. A preparation method of a histidine-triggered organic hydrogel fluorescent probe is characterized in that histidine is used as a fluorescent trigger, and Zr is used as a fluorescent trigger 4+ As precursors and gel inducers, N-dimethylformamide and H are used 2 O is used as a mixed solvent to construct a histidine-triggered metal organic hydrogel fluorescent switch probe Zr-MOG-His; DMF and H 2 O was transferred into the reaction vessel and then shaken well until thoroughly mixed, DMF and H 2 The volume ratio of O is 3:5-9:1; adding ligand trimesic acid into the reaction vessel, wherein the molar ratio of His to trimesic acid is 1:1, mixing and dissolving; the reaction vessel is sufficiently vibrated for 10-30min until the organic ligand in the system is completely dissolved, then 0.05mmoL-1 mole of Zr is added 4+ Adding into a mixed solvent; the reaction bodyHeating and vibrating, and then placing into a drying oven, heating at 80-120deg.C for 30min-12 min h to form white columnar gel.
2. The process according to claim 1, wherein DMF and H 2 The volume ratio of O is 7:3.
3. An organic hydrogel fluorescent probe prepared by the preparation method according to claim 1 or 2.
4. Use of the organic hydrogel fluorescent probe according to claim 3 for the preparation of a probe for detecting and capturing vitamins or antibiotics remaining in water, said vitamins or antibiotics being: rutin, beta-carotene, vancomycin, nitrofurantoin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110175668.XA CN113004315B (en) | 2021-02-09 | 2021-02-09 | Histidine-triggered organic hydrogel fluorescent probe and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110175668.XA CN113004315B (en) | 2021-02-09 | 2021-02-09 | Histidine-triggered organic hydrogel fluorescent probe and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113004315A CN113004315A (en) | 2021-06-22 |
CN113004315B true CN113004315B (en) | 2023-05-26 |
Family
ID=76384311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110175668.XA Active CN113004315B (en) | 2021-02-09 | 2021-02-09 | Histidine-triggered organic hydrogel fluorescent probe and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113004315B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110054586A (en) * | 2019-04-16 | 2019-07-26 | 西北师范大学 | A kind of rare earth metal complex gel is prepared and its in the application for detecting histidine |
CN110358109A (en) * | 2019-08-14 | 2019-10-22 | 安徽大学 | A kind of luminous Zr-MOG metal organogel and its synthetic method |
CN111778015A (en) * | 2020-06-16 | 2020-10-16 | 安徽大学 | Zr4+Induced metal organic gel fluorescent switch sensing material and preparation method and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110082328A (en) * | 2019-05-05 | 2019-08-02 | 江南大学 | A kind of carbon quantum dot-molecular engram fluorescent sensor material and its preparation method and application detecting chloramphenicol |
-
2021
- 2021-02-09 CN CN202110175668.XA patent/CN113004315B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110054586A (en) * | 2019-04-16 | 2019-07-26 | 西北师范大学 | A kind of rare earth metal complex gel is prepared and its in the application for detecting histidine |
CN110358109A (en) * | 2019-08-14 | 2019-10-22 | 安徽大学 | A kind of luminous Zr-MOG metal organogel and its synthetic method |
CN111778015A (en) * | 2020-06-16 | 2020-10-16 | 安徽大学 | Zr4+Induced metal organic gel fluorescent switch sensing material and preparation method and application thereof |
Non-Patent Citations (1)
Title |
---|
基于碳点"开关"型荧光探针在组氨酸检测中的研究;陶慧林 等;《光谱学与光谱分析》;第36卷(第04期);第1013-1016页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113004315A (en) | 2021-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zeng et al. | Dual-readout aptasensing of antibiotic residues based on gold nanocluster-functionalized MnO 2 nanosheets with target-induced etching reaction | |
Wang et al. | Multicolor FRET silica nanoparticles by single wavelength excitation | |
Zhang et al. | An upconversion nanosensor for rapid and sensitive detection of tetracycline in food based on magnetic-field-assisted separation | |
Yan et al. | Functionalized carbon dots of thiazole derivatives based on inner filter effect for tetracyclines detection | |
Haiping et al. | Immunochromatographic assay for the detection of antibiotics in animal-derived foods: A review | |
Wu et al. | Simultaneous detection of microcysin-LR and okadaic acid using a dual fluorescence resonance energy transfer aptasensor | |
Li et al. | A hydrogel microsphere-based sensor for dual and highly selective detection of Al3+ and Hg2+ | |
Wu et al. | Recent progress of fluorescence sensors for histamine in foods | |
Wang et al. | Efficient fabrication of ratiometric fluorescence imprinting sensors based on organic-inorganic composite materials and highly sensitive detection of oxytetracycline in milk | |
CN112898965A (en) | Preparation and use method of ratiometric fluorescent probe for visual differential detection | |
Shokri et al. | Virus-directed synthesis of emitting copper nanoclusters as an approach to simple tracer preparation for the detection of Citrus Tristeza Virus through the fluorescence anisotropy immunoassay | |
WO2023185543A1 (en) | Preparation and detection methods for dual-channel visualized multicolor fluorescent probe | |
CN113390846A (en) | Application of sulfur quantum dots as fluorescent probe in tetracycline detection | |
Wang et al. | Fluorescent identification and detection of Staphylococcus aureus with carboxymethyl chitosan/CdS quantum dots bioconjugates | |
Wang et al. | A novel PEG-mediated boric acid functionalized magnetic nanomaterials based fluorescence biosensor for the detection of Staphylococcus aureus | |
Zhang et al. | Colorimetric detection of bis-phosphorylated peptides using zinc (ii) dipicolylamine-appended gold nanoparticles | |
Li et al. | Energy transfer mediated rapid and visual discrimination of tetracyclines and quercetin in food by using N, Cu Co-doped carbon dots | |
CN106443003A (en) | Fluorescent quenching test paper strip based on aptamer specific recognition and preparation method and application thereof | |
CN107722968B (en) | A kind of preparation method of the Ciprofloxacin ratio fluorescent probe based on nano-complex | |
Wang et al. | UiO-66-NH 2 based fluorescent sensing for detection of tetracyclines in milk | |
Singh et al. | Drug and nanoparticle mediated rapid naked eye water test for pathogens detection | |
Zheng et al. | Rapid and selective detection of Bacillus cereus in food using cDNA-based up-conversion fluorescence spectrum copy and aptamer modified magnetic separation | |
CN113004315B (en) | Histidine-triggered organic hydrogel fluorescent probe and preparation method and application thereof | |
CN101776690A (en) | Immunoassays kit of microcystin-LR and detection method thereof | |
Mohammed Ameen et al. | Three in one: coordination-induced emission for inherent fluorescent Al-MOF synthesis combined with inner filter effect@ aggregation-induced emission mechanisms for designing color tonality and ratiometric sensing platforms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |